Pluri Inc. agreed to sell 1,200,000 common shares and pre-funded warrants for up to 1,028,940 additional shares, with expected net proceeds of approximately $2,984,808. The transaction gives investors exposure to new securities while directing funds to corporate development, general purposes and working capital.
Key Highlights
- Pre-funded warrants carry an initial exercise price of $0.00001 per share and are immediately exercisable.
- Directors and executive officers entered lock-up agreements covering their company securities after closing, subject to limited exceptions.
- The offering comprises 1,200,000 common shares and pre-funded warrants for up to 1,028,940 additional common shares.
Pluri Inc. (NASDAQ: PLUR) agreed to sell 1,200,000 common shares and pre-funded warrants for up to 1,028,940 additional common shares in a registered direct offering. The shares are priced at $1.50 each, while the pre-funded warrants are priced at $1.49999. Pluri expects approximately $2,984,808 in net proceeds for corporate development, general purposes and working capital.
$1.50 Offering Pairs Shares With Pre-Funded Warrants
The securities purchase agreement was signed on August 26, 2026, with an institutional investor. Each pre-funded Warrant carries an initial exercise price of $0.00001 per share, is immediately exercisable and remains available until fully exercised.
The common warrants have an exercise price of $1.65 per share. They become exercisable after an initial Waiting Period and remain exercisable for a defined period from that date.
Proceeds Directed to Corporate Development and Working Capital
Pluri said the net proceeds are intended for corporate development, general corporate purposes and working capital. Directors and executive officers entered lock-up agreements restricting transactions involving their company securities after closing, subject to limited exceptions.
The private-placement securities were sold without a public offering or general solicitation and were not registered under U.S. securities laws or applicable state securities laws.
Peers Moving on This News
- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) up 0.6%
- Chemomab Therapeutics Ltd. (NASDAQ: CMMB) little changed
- Enlivex Ltd. (NASDAQ: ENLV) up 1.0%




Please wait processing your request...